A Study To Evaluate The Dose Response And Safety Of PHA-794428 In Adults With Growth Hormone Deficiency
Status:
Terminated
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore the safety, toleration and dose response of
PHA-794428 after multiple weekly injections in male and female growth hormone deficient
patients.